Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Baxter
Colorcon
Boehringer Ingelheim

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Arimoclomol


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Arimoclomol?

Arimoclomol is an investigational drug.

There have been 10 clinical trials for Arimoclomol. The most recent clinical trial was a Phase 3 trial, which was initiated on July 31st 2018.

The most common disease conditions in clinical trials are Amyotrophic Lateral Sclerosis, Sclerosis, and Motor Neuron Disease. The leading clinical trial sponsors are Orphazyme, University of Kansas Medical Center, and CytRx.

There are seventy-five US patents protecting this investigational drug and eight hundred and two international patents.

Recent Clinical Trials for Arimoclomol
TitleSponsorPhase
Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension TrialOrphazymePhase 3
Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension TrialUniversity College, LondonPhase 3
Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension TrialUniversity of Kansas Medical CenterPhase 3

See all Arimoclomol clinical trials

Clinical Trial Summary for Arimoclomol

Top disease conditions for Arimoclomol
Top clinical trial sponsors for Arimoclomol

See all Arimoclomol clinical trials

US Patents for Arimoclomol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Arimoclomol ⤷  Try it Free Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder Axovant Sciences GmbH (Basel, CH) ⤷  Try it Free
Arimoclomol ⤷  Try it Free Increase of protein synthesis ameliorates synaptopathy-related neurological disorders Academia Sinica (Taipei, TW) ⤷  Try it Free
Arimoclomol ⤷  Try it Free Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Axovant Sciences GmbH (Basel, CH) ⤷  Try it Free
Arimoclomol ⤷  Try it Free Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same ENTERIN LABORATORIES, INC. (Merion, PA) ⤷  Try it Free
Arimoclomol ⤷  Try it Free Compositions for treating amyotrophic lateral sclerosis PHARNEXT (Issy les Moulineaux, FR) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Arimoclomol

Drugname Country Document Number Estimated Expiration Related US Patent
Arimoclomol Argentina AR104982 2035-06-12 ⤷  Try it Free
Arimoclomol Australia AU2016276966 2035-06-12 ⤷  Try it Free
Arimoclomol Canada CA2989343 2035-06-12 ⤷  Try it Free
Arimoclomol China CN109562085 2035-06-12 ⤷  Try it Free
Arimoclomol European Patent Office EP3307260 2035-06-12 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Baxter
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.